Inventor · disambiguated record
David A. Zopf
Also filed as: ZOPF DAVID · ZOPF DAVID A · ZOPF DAVID ADAM
47 granted patents·36 pending applications·2,070 citations·filing 1995–2025
99Inventor score
Files withNEOSE TECHNOLOGIES INC36NOVO NORDISK AS15DEFREES SHAWN13UNIV MICHIGAN REGENTS11UNIV MICHIGAN2
Top patents by PatentIndex Score
83 records- 0198US8063015B2Glycopegylation methods and proteins/peptides produced by the methodsDEFREES SHAWN·Filed 2009·Granted Nov 22, 2011·54 cites·19 claims
- 0298US7473680B2Remodeling and glycoconjugation of peptidesNEOSE TECHNOLOGIES INC·Filed 2005·Granted Jan 6, 2009·88 cites·43 claims
- 0398US7338933B2O-linked glycosylation of peptidesNEOSE TECHNOLOGIES INC·Filed 2005·Granted Mar 4, 2008·111 cites·20 claims
- 0498US7179617B2Factor IX: remolding and glycoconjugation of Factor IXNEOSE TECHNOLOGIES INC·Filed 2003·Granted Feb 20, 2007·130 cites·108 claims
- 0598US7138371B2Remodeling and glycoconjugation of peptidesNEOSE TECHNOLOGIES INC·Filed 2002·Granted Nov 21, 2006·142 cites·30 claims
- 0698US7125843B2Glycoconjugates including more than one peptideNEOSE TECHNOLOGIES INC·Filed 2003·Granted Oct 24, 2006·126 cites·20 claims
- 0797US7956032B2Glycopegylated granulocyte colony stimulating factorNOVO NORDISK AS·Filed 2005·Granted Jun 7, 2011·32 cites·10 claims
- 0897US7276475B2Remodeling and glycoconjugation of peptidesNEOSE TECHNOLOGIES INC·Filed 2006·Granted Oct 2, 2007·62 cites·23 claims
- 0997US7157277B2Factor VIII remodeling and glycoconjugation of Factor VIIINEOSE TECHNOLOGIES INC·Filed 2003·Granted Jan 2, 2007·84 cites·104 claims
- 1096US8633157B2Glycopegylated erythropoietinDEFREES SHAWN·Filed 2005·Granted Jan 21, 2014·24 cites·53 claims
- 1196US7439043B2Galactosyl nucleotide sugarsNEOSE TECHNOLOGIES INC·Filed 2003·Granted Oct 21, 2008·68 cites·27 claims
- 1296US7265084B2Glycopegylation methods and proteins/peptides produced by the methodsNEOSE TECHNOLOGIES INC·Filed 2003·Granted Sep 4, 2007·55 cites·69 claims
- 1396US7265085B2Glycoconjugation methods and proteins/peptides produced by the methodsNEOSE TECHNOLOGIES INC·Filed 2003·Granted Sep 4, 2007·57 cites·94 claims
- 1496US7214660B2Erythropoietin: remodeling and glycoconjugation of erythropoietinNEOSE TECHNOLOGIES INC·Filed 2003·Granted May 8, 2007·82 cites·32 claims
- 1596US7173003B2Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSFNEOSE TECHNOLOGIES INC·Filed 2003·Granted Feb 6, 2007·69 cites·103 claims
- 1695US8716239B2Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSFDEFREES SHAWN·Filed 2007·Granted May 6, 2014·23 cites·4 claims
- 1795US8716240B2Erythropoietin: remodeling and glycoconjugation of erythropoietinDEFREES SHAWN·Filed 2007·Granted May 6, 2014·27 cites·22 claims
- 1895US8361961B2O-linked glycosylation of peptidesBIOGENERIX AG·Filed 2005·Granted Jan 29, 2013·37 cites·15 claims
- 1995US7795210B2Protein remodeling methods and proteins/peptides produced by the methodsNOVO NORDISK AS·Filed 2003·Granted Sep 14, 2010·65 cites·24 claims
- 2095US7696163B2Erythropoietin: remodeling and glycoconjugation of erythropoietinNOVO NORDISK AS·Filed 2003·Granted Apr 13, 2010·65 cites·77 claims
- 2195US7416858B2Pharmaceutical compositions of glycoconjugatesNEOSE TECHNOLOGIES INC·Filed 2002·Granted Aug 26, 2008·55 cites·120 claims
- 2295US7405198B2Glycopegylated erythropoietinNEOSE TECHNOLOGIES INC·Filed 2004·Granted Jul 29, 2008·57 cites·36 claims
- 2395US7399613B2Sialic acid nucleotide sugarsNEOSE TECHNOLOGIES INC·Filed 2003·Granted Jul 15, 2008·44 cites·25 claims
- 2494US7842661B2Glycopegylated erythropoietin formulationsNOVO NORDISK AS·Filed 2006·Granted Nov 30, 2010·31 cites·30 claims
- 2594US7226903B2Interferon beta: remodeling and glycoconjugation of interferon betaNEOSE TECHNOLOGIES INC·Filed 2003·Granted Jun 5, 2007·52 cites·113 claims
- 2693US8853161B2Glycopegylation methods and proteins/peptides produced by the methodsDEFREES SHAWN·Filed 2011·Granted Oct 7, 2014·13 cites·17 claims
- 2793US7297511B2Interferon alpha: remodeling and glycoconjugation of interferon alphaNEOSE TECHNOLOGIES INC·Filed 2003·Granted Nov 20, 2007·40 cites·155 claims
- 2891US8268967B2Glycopegylated interferon αDEFREES SHAWN·Filed 2005·Granted Sep 18, 2012·24 cites·31 claims
- 2989US8008252B2Factor VII: remodeling and glycoconjugation of Factor VIINOVO NORDISK AS·Filed 2003·Granted Aug 30, 2011·34 cites·87 claims
- 3087US11564792B2Ear tissue scaffold implant for auricular tissue reconstructionUNIV MICHIGAN REGENTS·Filed 2018·Granted Jan 31, 2023·3 cites·21 claims
- 3187US8076292B2Factor VIII: remodeling and glycoconjugation of factor VIIIDEFREES SHAWN·Filed 2006·Granted Dec 13, 2011·6 cites·110 claims
- 3286US5514660AMethod for treating and inhibiting gastric and duodenal ulcersNEOSE PHARM INC·Filed 1995·Granted May 7, 1996·64 cites·18 claims
- 3385US5883079AMethod for inhibiting H. pylori infection in mammalian tissueNEOSE TECHNOLOGIES INC·Filed 1998·Granted Mar 16, 1999·56 cites·7 claims
- 3483US9029331B2Glycopegylated granulocyte colony stimulating factorDEFREES SHAWN·Filed 2006·Granted May 12, 2015·3 cites·4 claims
- 3583US8911967B2One pot desialylation and glycopegylation of therapeutic peptidesDEFREES SHAWN·Filed 2010·Granted Dec 16, 2014·5 cites·29 claims
- 3683US2024398552A1Scaffold For Nasal Tissue EngineeringUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 3781US12064340B2Scaffold for nasal tissue engineeringUNIV MICHIGAN REGENTS·Filed 2022·Granted Aug 20, 2024·0 cites·24 claims
- 3881US11458012B2Scaffold for nasal tissue engineeringUNIV MICHIGAN REGENTS·Filed 2019·Granted Oct 4, 2022·3 cites·20 claims
- 3981US5736533ABacterial inhibition with an oligosaccharide compoundNEOSE TECHNOLOGIES INC·Filed 1995·Granted Apr 7, 1998·51 cites·16 claims
- 4078US8916360B2Glycopegylated erythropoietinDEFREES SHAWN·Filed 2011·Granted Dec 23, 2014·3 cites·8 claims
- 4178US6001819ABacterial inhibition with an oligosaccharide compoundNEOSE TECHNOLOGIES INC·Filed 1998·Granted Dec 14, 1999·42 cites·3 claims
- 4277US5753630AMethod for treating and inhibiting gastric and duodenal ulcersNEOSE TECHNOLOGIES INC·Filed 1996·Granted May 19, 1998·36 cites·9 claims
- 4376US6706497B2Methods for producing sialyloligosaccharides in a dairy sourceNEOSE TECHNOLOGIES INC·Filed 2001·Granted Mar 16, 2004·4 cites·36 claims
- 4476US6323008B1Methods for producing sialyloligosaccharides in a dairy sourceNEOSE TECHNOLOGIES INC·Filed 1997·Granted Nov 27, 2001·27 cites·30 claims
- 4572US9050304B2Methods of treatment using glycopegylated G-CSFZOPF DAVID A·Filed 2008·Granted Jun 9, 2015·3 cites·37 claims
- 4668US2008070275A1Factor VIII: Remodeling and glycoconjugation of factor VIIINEOSE TECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 4767US2014170728A1Factor IX: Remodeling and Glycoconjugation of Factor IXNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 4866US2023172706A1Ear tissue scaffold implant for auricular tissue reconstructionUNIV MICHIGAN REGENTS·Filed 2023·Application pending·0 cites
- 4965US2016193353A1Factor viii: remodeling and glycoconjugation of factor viiiNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 5065US2014294762A1Glycopegylation methods and proteins/peptides produced by the methodsNOVO NORDISK AS·Filed 2014·Application pending·0 cites
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David A. Zopf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →